Scholars@Duke

Enhanced oncolytic virotherapy through oxidative stress inhibition.

Publication ,  Journal Article
Congdon, KL; Sampson, JH
Published in: Mol Ther
November 2013
Published version (DOI) Link to item

Duke Scholars

John Howard Sampson
Author John Howard Sampson Neurosurgery

Published In

Mol Ther

DOI

10.1038/mt.2013.227

EISSN

1525-0024

Publication Date

November 2013

Volume

21

Issue

11

Start / End Page

1981 / 1983

Location

United States

Related Subject Headings

  • Oncolytic Virotherapy
  • Neural Stem Cells
  • Glioma
  • Biotechnology
  • Animals
  • Adenoviridae
  • Acetylcysteine
  • 3206 Medical biotechnology
  • 3202 Clinical sciences
  • 3105 Genetics
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Congdon, K. L., & Sampson, J. H. (2013). Enhanced oncolytic virotherapy through oxidative stress inhibition. Mol Ther, 21(11), 1981–1983. https://doi.org/10.1038/mt.2013.227
Congdon, Kendra L., and John H. Sampson. “Enhanced oncolytic virotherapy through oxidative stress inhibition.” Mol Ther 21, no. 11 (November 2013): 1981–83. https://doi.org/10.1038/mt.2013.227.
Congdon KL, Sampson JH. Enhanced oncolytic virotherapy through oxidative stress inhibition. Mol Ther. 2013 Nov;21(11):1981–3.
Congdon, Kendra L., and John H. Sampson. “Enhanced oncolytic virotherapy through oxidative stress inhibition.” Mol Ther, vol. 21, no. 11, Nov. 2013, pp. 1981–83. Pubmed, doi:10.1038/mt.2013.227.
Congdon KL, Sampson JH. Enhanced oncolytic virotherapy through oxidative stress inhibition. Mol Ther. 2013 Nov;21(11):1981–1983.

Published In

Mol Ther

DOI

10.1038/mt.2013.227

EISSN

1525-0024

Publication Date

November 2013

Volume

21

Issue

11

Start / End Page

1981 / 1983

Location

United States

Related Subject Headings

  • Oncolytic Virotherapy
  • Neural Stem Cells
  • Glioma
  • Biotechnology
  • Animals
  • Adenoviridae
  • Acetylcysteine
  • 3206 Medical biotechnology
  • 3202 Clinical sciences
  • 3105 Genetics